Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
about
Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis.Global Phosphoproteomic Analysis of Insulin/Akt/mTORC1/S6K Signaling in Rat Hepatocytes.Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.
P2860
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@en
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@nl
type
label
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@en
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@nl
prefLabel
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@en
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.
@nl
P2860
P356
P1433
P1476
Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling
@en
P2093
Richard K Bruick
Yonghao Yu
P2860
P2888
P304
P356
10.1038/NCB3311
P50
P577
2016-02-08T00:00:00Z